Skip to main content
. Author manuscript; available in PMC: 2012 Jul 20.
Published in final edited form as: J Med Primatol. 2007 Aug;36(4-5):266–275. doi: 10.1111/j.1600-0684.2007.00244.x

Table 1.

Summary of study organization, characteristics of the male rhesus monkeys, treatments and peak plasma vRNA levels after SIV challenge

Animal number Origin Age at challenge Mamu- A*01 status Attenuated SHIV89.6 infection Depo-Provera treatment Peak plasma vRNAIoglO (copies/ml)
34569 Ch 7 year 2 months − + None 3.53
34484 Ch 8 year 5 months − + None 4.48
34537 Ch 7 year 11 months − + None 2.93
34549 Ch 6 year − + None 5.74
30706 1/8 Ch 7 year 1 months − + + 4.71
34573 Ch 9 year 6 months − + + 4.76
32212 In 5 year 1 months + + + 3.79
34554 Ch 7 year − − None 6.91
34566 Ch 6 year 2 months − − None 7.23
32383 1/8 Ch 5 year 1 months − − None 7.34
33583 Ch 9 year 11 months − − None 6.95

Ch, Chinese-origin rhesus monkeys; In, Indian-origin rhesus monkeys.